How long does Revlimid work for multiple myeloma?
Results showed that patients receiving Revlimid lived 39 months without their disease worsening, compared with 20 months for the observation arm. This translated into a 54% reduction in the risk of disease progression or death.
What is the monthly cost of Revlimid?
Celgene launched Revlimid in 2005 at a price of $215 per pill. After more than 20 price hikes, the drug now costs $763 per pill, or $16,023 per month.
How long can you take Revlimid?
You won't take the drug on days 22 to 28. Revlimid can be taken for up to 12 cycles. Your doctor will likely prescribe Revlimid with the medication rituximab (Truxima, Rituxan).
How do I access Revlimid?
To avoid embryo-fetal exposure to lenalidomide, REVLIMID is only available through a restricted distribution program, the Lenalidomide REMS program. Information about the Lenalidomide REMS program is available at www.celgeneriskmanagement.com or by calling the manufacturer's toll-free number 1-888-423-5436.
What is the life expectancy for multiple myeloma Stage 3?
Life Expectancy With Stage III Multiple Myeloma This is called the 5-year relative survival rate. Current research puts the 5-year survival rate for stage III multiple myeloma at about 53%. However, there are various factors other than stage that can influence your chance of survival.
Is Revlimid a chemotherapy?
Revlimid | Chemotherapy Drug Information | Chemocare.com.
What is the success rate of Revlimid?
Patients who took REVLIMID and dexamethasone continuously had a 75% response rate compared to 73% of patients who took REVLIMID and dexamethasone for only 18 months and 62% of patients who took the combination of melphalan, prednisone, and thalidomide.
What are the long term effects of taking Revlimid?
It's possible that Revlimid can cause long-term side effects. For example, this medication may cause: liver problems, such as liver failure. other types of cancer, such as skin cancer or leukemia.
What happens if you touch Revlimid?
Serious skin reactions can happen with REVLIMID and may cause death. Call your healthcare provider right away if you have any skin reaction while taking REVLIMID. Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells.
Is revlimid a high risk medication?
VO: REVLIMID (lenalidomide) may cause serious side effects, including risk to unborn babies, risk of low blood counts and blood clots. There are safety considerations to be aware of with REVLIMID. That is why REVLIMID is only available through a restricted distribution program, Lenalidomide REMS.
Does Revlimid cause weight gain?
Lenalidomide may cause a serious type of reaction called tumor lysis syndrome. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.
Does Revlimid cause weight loss?
Treatment with REVLIMID can cause diarrhea. Diarrhea happens when your stools become watery and you go to the bathroom much more often than usual. Your doctor needs to know if you have diarrhea. Diarrhea can cause weight loss, fluid loss (dehydration), poor appetite, and weakness.
Is there a generic for Revlimid?
A generic for Revlimid is finally available. On March 7, 2022 Teva Pharmaceuticals released lenalidomide capsules, the generic version of Revlimid in the United States. They will come in strengths of 5mg, 10mg, 15mg and 25mg.
Does Medicare cover multiple myeloma?
"As most patients with myeloma in the United States are covered by Medicare, our results have important implications both for the clinicians who care for these patients and for health-care policy that tackles coverage of oral and parenteral anticancer therapy."
What tier drug is Revlimid?
What drug tier is Revlimid typically on? Medicare prescription drug plans typically list Revlimid on Tier 5 of their formulary. Generally, the higher the tier, the more you have to pay for the medication.
What is the generic name for Revlimid?
Generic Name: lenalidomide. Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS).
How BMS Access Support May Help
Find out how BMS can work with patients and their healthcare providers to help access a prescribed BMS medication.
Financial Support Options
There may be programs and services that could help with the cost of treatment. Learn about what options are available.
Additional Resources
We provide videos, tools, and other resources that may help with your access and reimbursement needs.
How to contact Revlimid?
Your experience could help fellow patients, caregivers, and healthcare providers. To contact us, call 1-800-657-9801 or email [email protected].
What do you need to know before prescribing Revlimid?
Before you begin taking REVLIMID, you must read and agree to all of the instructions in the REVLIMID REMS ® program. Before prescribing REVLIMID, your healthcare provider will explain the REVLIMID REMS program to you and have you sign the Patient-Physician Agreement Form.
What is Revlimid used for?
REVLIMID ® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).
Is Revlimid a prescription?
REVLIMID ® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.
How old do you have to be to sign up for Revlimid?
Must be 18 years of age or older to sign up. Please see Privacy Policy to learn more about Bristol Myers Squibb's use of submitted information.
Is Revlimid safe for babies?
VO: REVLIMID (lenalidomide) may cause serious side effects, including risk to unborn babies, risk of low blood counts and blood clots. There are safety considerations to be aware of with REVLIMID. That is why REVLIMID is only available through a restricted distribution program, REVLIMD REMS ®. Please listen for important safety information throughout this video.
Can you breastfeed with Revlimid?
are breastfeeding. Do not breastfeed during treatment with REVLIMID. It is not known if REVLIMID passes into your breast milk and can harm your baby.
Patients With Commercial (Private) Insurance
The BMS Oncology Co-Pay Assistance Program helps commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements. Eligible patients may pay as little as $10 per one-month supply, up to a maximum of $15,000 per calendar year.
Patients With Insurance Through Federal Healthcare Programs
Patients insured through Federal Healthcare Programs are not eligible for co-pay assistance programs sponsored by Bristol Myers Squibb.
Patients Without Prescription Drug Coverage or Who Are Underinsured
For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can make a referral to independent charitable foundations that may be able to help.
What is Celgene patient support?
Celgene Patient Support® is here to help you and your loved ones understand the financial help that may be available for REVLIMID®.
How to contact Celgene insurance?
Call your Specialist at 1-800-931-8691. If you have commercial insurance, you may qualify for the Celgene Commercial Co-pay Program. If you qualify, your out-of-pocket co-pay responsibility will be $25(subject to annual benefit limit) for REVLIMID.
Is Revlimid a trademark?
Celgene Patient Support®and REVLIMID are registered trademarks of Celgene Corporation. Other trademarks are the property of their respective owners. © 2019 Celgene Corporation 09/19 US-REV-19-0425
Warnings and Precautions
- Embryo-Fetal Toxicity: See Boxed WARNINGS. 1. Females of Reproductive Potential: See Boxed WARNINGS. 2. Males: Lenalidomide is present in the semen of patients receiving the drug. Males must always use a latex or synthetic condom during any sexual contact with females of reproductive potential while taking REVLIMID and for up to 4 weeks after discontinuing REVLIMI…
Multiple Myeloma
- In newly diagnosed: The most frequently reported Grade 3 or 4 reactions included neutropenia, anemia, thrombocytopenia, pneumonia, asthenia, fatigue, back pain, hypokalemia, rash, cataract, lymphop...
- The most common adverse reactions reported in ≥20% (Arm Rd Continuous): diarrhea (45%), anemia (44%), neutropenia (35%), fatigue (33%), back pain (32%), asthenia (28%), insomnia (2…
- In newly diagnosed: The most frequently reported Grade 3 or 4 reactions included neutropenia, anemia, thrombocytopenia, pneumonia, asthenia, fatigue, back pain, hypokalemia, rash, cataract, lymphop...
- The most common adverse reactions reported in ≥20% (Arm Rd Continuous): diarrhea (45%), anemia (44%), neutropenia (35%), fatigue (33%), back pain (32%), asthenia (28%), insomnia (28%), rash (26%),...
- Maintenance Therapy Post Auto-HSCT:The most frequently reported Grade 3 or 4 reactions in ≥20% (REVLIMID arm) included neutropenia, thrombocytopenia, and leukopenia. The serious adverse reactions o...
- The most frequently reported adverse reactions in ≥20% (REVLIMID arm) across both mainte…
Drug Interactions
- Periodically monitor digoxin plasma levels due to increased Cmaxand AUC with concomitant REVLIMID therapy. Patients taking concomitant therapies such as ESAs or estrogen-containing therapies may have an increased risk of thrombosis. It is not known whether there is an interaction between dexamethasone and warfarin. Close monitoring of PT and INR is recommen…
Use in Specific Populations
- PREGNANCY: See Boxed WARNINGS:If pregnancy does occur during treatment, immediately discontinue the drug and refer patient to an obstetrician/gynecologist experienced in reproductive toxicity for f...
- LACTATION: There is no information regarding the presence of lenalidomide in human milk, t…